In 2009, Li-Duan Zheng and colleagues13 reported that of the 80 CRC patients studied, 65 (81.25%) tested positive for RELMβ, mainly in the cytoplasm of colon mucosa. This evidence concerns the gene RETNLB and colorectal carcinoma.